References
- Arsalan, A., Iqbal, Z., Tariq, M., Ayonrinde, O., Vincent, J. B., & Ayub, M. (2019). Association of smoked cannabis with treatment resistance in schizophrenia. Psychiatry Research, 278, 242–247. https://doi.org/10.1016/j.psychres.2019.06.023
- Bahorik, A. L., Newhill, C. E., Queen, C. C., & Eack, S. M. (2014). Under-reporting of drug use among individuals with schizophrenia: Prevalence and predictors. Psychological Medicine, 44(1), 61–69. https://doi.org/10.1017/S0033291713000548
- Crocker, A. G., Nicholls, T. L., Seto, M. C., Charette, Y., Côté, G., & Caulet, M. (2015). The National Trajectory Project of individuals found not criminally responsible on account of mental disorder in Canada. Part 2: The people behind the label. The Canadian Journal of Psychiatry, 60(3), 106–116. https://doi.org/10.1177/070674371506000305
- de Beaurepaire, R., Lukasiewicz, M., Beauverie, P., Castéra, S., Dagorne, O., Espaze, R., … Matheron, I. (2007). Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. European Psychiatry, 22(8), 540–548. https://doi.org/10.1016/j.eurpsy.2007.05.001
- Douglas, K. S., Hart, S. D., Webster, C. D., & Belfrage, H. (2013). HCR-20V3: Assessing risk for violence. User guide. Mental Health, Law, and Policy Institute, Simon Fraser University.
- Dupouy, J., Mémier, V., Catala, H., Lavit, M., Oustric, S., & Lapeyre-Mestre, M. (2014). Does urine drug abuse screening help for managing patients? A systematic review. Drug and Alcohol Dependence, 136, 11–20. https://doi.org/10.1016/j.drugalcdep.2013.12.009
- Eisen, J. S., Sivilotti, M. L., Boyd, K. U., Barton, D. G., Fortier, C. J., & Collier, C. P. (2004). Screening urine for drugs of abuse in the emergency department: Do test results affect physicians’ patient care decisions? Canadian Journal of Emergency Medicine, 6(2), 104–111. https://doi.org/10.1017/S1481803500009064
- Foti, D. J., Kotov, R., Guey, L. T., & Bromet, E. J. (2010). Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. American Journal of Psychiatry, 167(8), 987–993. https://doi.org/10.1176/appi.ajp.2010.09020189
- Fraser, A. D., & Zamecnik, J. (2002). Substance abuse monitoring by the Correctional Service of Canada. Therapeutic Drug Monitoring, 24(1), 187–191. https://doi.org/10.1097/00007691-200202000-00030
- Gore, S. M., Bird, A. G., & Strang, J. S. (1999). Random mandatory drugs testing of prisoners: A biased means of gathering information. Journal of Epidemiology and Biostatistics, 4(1), 3–9.
- Grech, A., Van Os, J., Jones, P. B., Lewis, S. W., & Murray, R. M. (2005). Cannabis use and outcome of recent onset psychosis. European Psychiatry, 20(4), 349–353. https://doi.org/10.1016/j.eurpsy.2004.09.013
- Hare, R. D. (2003). The Hare Psychopathy Checklist–Revised (2nd ed.). Multi-Health Systems.
- Kendrick, C., Basson, J., & Taylor, P. J. (2002). Substance misuse in a high security hospital: Period prevalence and an evaluation of screening. Criminal Behaviour and Mental Health, 12(2), 123–134. https://doi.org/10.1002/cbm.491
- Kivimies, K., Repo-Tiihonen, E., & Tiihonen, J. (2012). The substance use among forensic psychiatric patients. The American Journal of Drug and Alcohol Abuse, 38(4), 273–277. https://doi.org/10.3109/00952990.2011.643972
- Kolla, B. P., Callizo, G. L., & Schneekloth, T. D. (2019). Utility of urine drug testing in outpatient addiction evaluations. Journal of Addiction Medicine, 13(3), 188–192. https://doi.org/10.1097/ADM.0000000000000477
- Kraanen, F. L., Scholing, A., & Emmelkamp, P. M. (2012). Substance use disorders in forensic psychiatry: Differences among different types of offenders. International Journal of Offender Therapy and Comparative Criminology, 56(8), 1201–1219. https://doi.org/10.1177/0306624X11420252
- Leistico, A. M. R., Salekin, R. T., DeCoster, J., & Rogers, R. (2008). A large-scale meta-analysis relating the Hare measures of psychopathy to antisocial conduct. Law and Human Behavior, 32(1), 28–45. https://doi.org/10.1007/s10979-007-9096-6
- MacIntyre, D., McNamara, N., Irwin, D., Gray, C., & Darjee, R. (2004). Substance misuse in a high security hospital: Three years of urine drug testing at the State Hospital, Carstairs. Journal of Forensic Psychiatry & Psychology, 15(4), 606–619. https://doi.org/10.1080/1478994042000270274
- Manchikanti, L., Manchukonda, R., Pampati, V., Damron, K. S., Brandon, D. E., Cash, K., & McManus, C. D. (2006). Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician, 9(2), 123–129.
- Moeller, K. E., Kissack, J. C., Atayee, R. S., & Lee, K. C. (2017). Clinical interpretation of urine drug tests: What clinicians need to know about urine drug screens. Mayo Clinic Proceedings, 92(5), 774–796. https://doi.org/10.1016/j.mayocp.2016.12.007
- Ogloff, J. R., Lemphers, A., & Dwyer, C. (2004). Dual diagnosis in an Australian forensic psychiatric hospital: Prevalence and implications for services. Behavioral Sciences & the Law, 22(4), 543–562. https://doi.org/10.1002/bsl.604
- Penney, S. R., Marshall, L., & Simpson, A. I. F. (2018). A prospective study of pathways to hospital readmission in Canadian forensic psychiatric patients. The Journal of Forensic Psychiatry & Psychology, 29(3), 368–386. https://doi.org/10.1080/14789949.2017.1395061
- Penney, S. R., Marshall, L. A., & Simpson, A. I. (2016). The assessment of dynamic risk among forensic psychiatric patients transitioning to the community. Law and Human Behavior, 40(4), 374–386. https://doi.org/10.1037/lhb0000183
- Penney, S. R., Seto, M. C., Crocker, A. G., Nicholls, T. L., Grimbos, T., Darby, P. L., & Simpson, A. I. F. (2019). Changing characteristics of forensic psychiatric patients in Ontario: A population-based study from 1987 to 2012. Social Psychiatry and Psychiatric Epidemiology, 54(5), 627–638. https://doi.org/10.1007/s00127-018-1619-6
- Price, O., & Wibberley, C. (2012). An exploratory study investigating the impact of the procedures used to manage patient substance misuse on nurse–patient relationships in a medium secure forensic unit. Journal of Psychiatric and Mental Health Nursing, 19(8), 672–680. https://doi.org/10.1111/j.1365-2850.2011.01842.x
- Rzetelny, A., Zeller, B., Miller, N., City, K. E., Kirsh, K. L., & Passik, S. D. (2016). Counselors’ clinical use of definitive drug testing results in their work with substance-use clients: A qualitative study. International Journal of Mental Health and Addiction, 14(1), 64–80. https://doi.org/10.1007/s11469-015-9569-7
- Saitman, A., Park, H. D., & Fitzgerald, R. L. (2014). False-positive interferences of common urine drug screen immunoassays: A review. Journal of Analytical Toxicology, 38(7), 387–396. https://doi.org/10.1093/jat/bku075
- Schoeler, T., Petros, N., Di Forti, M., Klamerus, E., Foglia, E., Ajnakina, O., … Shetty, S. (2016). Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: An observational study. The Lancet Psychiatry, 3(10), 947–953. https://doi.org/10.1016/S2215-0366(16)30188-2
- Simpson, A. I. F., Penney, S. R., Seto, M., Crocker, A. G., Nicholls, T. N., & Darby, P. L. (2014). Changing characteristics of the Review Board population in Ontario: A population-based study from 1987-2012. Report commissioned by the Ontario Ministry of Health and Long-Term Care.
- Substance Abuse and Mental Health Services Administration (2012). Clinical drug testing in primary care. Substance Abuse and Mental Health Services Administration. HHS Publication (SMA) 12-4668. https://store.samhsa.gov/shin/content/SMA12-4668/SMA12-4668.pdf.
- Tijdink, J. K., van den Heuvel, J., Vasbinder, E. C., van de Ven, P. M., & Honig, A. (2011). Does on-site urine toxicology screening have an added diagnostic value in psychiatric referrals in an emergency setting? General Hospital Psychiatry, 33(6), 626–630. https://doi.org/10.1016/j.genhosppsych.2011.07.008
- Wilkie, T., Penney, S. R., Fernane, S., & Simpson, A. I. F. (2014). Characteristics and motivations of absconders from forensic mental health services: A case-control study. BMC Psychiatry, 14(1), 91. https://doi.org/10.1186/1471-244x-14-91
- Wurst, F. M., Vogel, R., Jachau, K., Varga, A., Alling, C., Alt, A., & Skipper, G. E. (2003). Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcoholism, Clinical and Experimental Research, 27(3), 471–476. https://doi.org/10.1097/01.ALC.0000057942.57330.E2
- Zammit, S., Moore, T. H., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2008). Effects of cannabis use on outcomes of psychotic disorders: Systematic review. The British Journal of Psychiatry, 193(5), 357–363. https://doi.org/10.1192/bjp.bp.107.046375